Radiopharmaceuticals— Companies & Signals
Radiopharmaceuticals leverage radioactive isotopes to precisely target and treat diseases, offering a novel therapeutic modality with significant potential in oncology and other areas. This growing field represents a key innovation in precision medicine, addressing unmet clinical needs and driving demand for advanced diagnostic and therapeutic solutions. 7 public companies above the $50M floor. Last 90 days: 3 red 8-Ks, 0 insider cluster-buys, 0 running hot in the press.
7
Companies
3
Red 8-Ks · 90d
0
Insider clusters
0
🔥 Media-hot
Companies in Radiopharmaceuticals
Refine in search →| # | Ticker | Company | Sector | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MOLN | MOLECULAR PARTNERS AG | Healthcare | $154.2M | +4.2% | +0.3% | 9K | — | |
| 2 | IMNM | Immunome Inc. | Healthcare | $2.1B | +5.4% | +9.7% | 1.6M | — | |
| 3 | CRNX | Crinetics Pharmaceuticals, Inc. | Healthcare | $3.6B | +0.7% | +4.4% | 884K | — | red 8-K |
| 4 | BCYC | BICYCLE THERAPEUTICS PLC | Healthcare | $282.7M | +1.2% | +4.3% | 784K | — | |
| 5 | MIR | Mirion Technologies, Inc. | Healthcare | $4.1B | -5.4% | -5.8% | 4.5M | — | red 8-K |
| 6 | JANX | Janux Therapeutics, Inc. | Healthcare | $826.9M | +2.6% | +6.9% | 1.2M | — | red 8-K |
| 7 | MGTX | MeiraGTx Holdings plc | Healthcare | $888.1M | +3.5% | +9.2% | 683K | — |
Membership is matched by keyword from companies’ SEC business descriptions (10-K Item 1) — deterministic, not AI inference. May not be exhaustive; not investment advice.